Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

Shifa Hospital Faisalabad begins operations

Waves restarts AC business after four-year hiatus

PSX Opening Bell: Bulls Hit the Ground Running

Name	Price/Vol	%Chg/NChg
KSE100	176,112.68 277.60M	2.15% 3712.77
ALLSHR	105,983.07 553.13M	1.98% 2055.17
KSE30	52,613.70 144.19M	2.31% 1185.53
KMI30	252,273.16 139.81M	2.24% 5530.08
KMIALLSHR	68,822.47 336.41M	1.96% 1322.53
BKTi	48,008.92 29.72M	2.20% 1034.63
OGTi	35,561.44 6.34M	1.07% 377.91

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	65,975.00	66,055.00 63,430.00	2315.00 3.64%
BRENT CRUDE	82.93	85.93 82.86	-4.40 -5.04%
RICHARDS BAY COAL MONTHLY	123.00	0.00 0.00	3.75 3.14%
ROTTERDAM COAL MONTHLY	131.00	0.00 0.00	0.00 0.00%
USD RBD PALM OLEIN	1,157.50	1,157.50 1,157.50	0.00 0.00%
CRUDE OIL - WTI	80.07	82.42 80.00	-4.81 -5.67%
SUGAR #11 WORLD	13.70	0.00 0.00	0.00 0.00%